NZ222911A - Method of relieving nausea and emesis by administering noroxymorphone derivatives; mixture of noroxymorphone derivatives and a narcotic analgesic - Google Patents

Method of relieving nausea and emesis by administering noroxymorphone derivatives; mixture of noroxymorphone derivatives and a narcotic analgesic

Info

Publication number
NZ222911A
NZ222911A NZ22291187A NZ22291187A NZ222911A NZ 222911 A NZ222911 A NZ 222911A NZ 22291187 A NZ22291187 A NZ 22291187A NZ 22291187 A NZ22291187 A NZ 22291187A NZ 222911 A NZ222911 A NZ 222911A
Authority
NZ
New Zealand
Prior art keywords
noroxymorphone derivatives
emesis
administering
mixture
method
Prior art date
Application number
NZ22291187A
Inventor
Leon I Goldberg
Original Assignee
Univ Chicago
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US07/092,470 priority Critical patent/US4861781A/en
Application filed by Univ Chicago filed Critical Univ Chicago
Publication of NZ222911A publication Critical patent/NZ222911A/en

Links

NZ22291187A 1986-03-07 1987-12-14 Method of relieving nausea and emesis by administering noroxymorphone derivatives; mixture of noroxymorphone derivatives and a narcotic analgesic NZ222911A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US07/092,470 US4861781A (en) 1986-03-07 1987-09-03 Quaternary derivatives of noroxymorphone which relieve nausea and emesis

Publications (1)

Publication Number Publication Date
NZ222911A true NZ222911A (en) 1990-11-27

Family

ID=22233375

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ22291187A NZ222911A (en) 1986-03-07 1987-12-14 Method of relieving nausea and emesis by administering noroxymorphone derivatives; mixture of noroxymorphone derivatives and a narcotic analgesic

Country Status (5)

Country Link
JP (1) JP2625457B2 (en)
CA (1) CA1315689C (en)
DK (1) DK167340B1 (en)
NZ (1) NZ222911A (en)
PH (1) PH22582A (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608075B2 (en) 1997-11-03 2003-08-19 The University Of Chicago Use of methylnaltrexone and related compounds
US7563899B2 (en) 2005-05-25 2009-07-21 Progenics Pharmaceuticals, Inc. (S)-N-methylnaltrexone
US7674904B2 (en) 2005-05-25 2010-03-09 Progenics Pharmaceuticals, Inc. Synthesis of R-N-methylnaltrexone
US8247425B2 (en) 2008-09-30 2012-08-21 Wyeth Peripheral opioid receptor antagonists and uses thereof
US8338446B2 (en) 2007-03-29 2012-12-25 Wyeth Llc Peripheral opioid receptor antagonists and uses thereof
US8471022B2 (en) 2008-02-06 2013-06-25 Progenics Pharmaceuticals, Inc. Preparation and use of (R),(R)-2,2′-bis-methylnaltrexone
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8546418B2 (en) 2007-03-29 2013-10-01 Progenics Pharmaceuticals, Inc. Peripheral opioid receptor antagonists and uses thereof
US8552025B2 (en) 2003-04-08 2013-10-08 Progenics Pharmaceuticals, Inc. Stable methylnaltrexone preparation
US8685995B2 (en) 2008-03-21 2014-04-01 The University Of Chicago Treatment with opioid antagonists and mTOR inhibitors
US9102680B2 (en) 2007-03-29 2015-08-11 Wyeth Llc Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US9662390B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6451806B2 (en) 1999-09-29 2002-09-17 Adolor Corporation Methods and compositions involving opioids and antagonists thereof
US6469030B2 (en) 1999-11-29 2002-10-22 Adolor Corporation Methods for the treatment and prevention of ileus
CA2625495A1 (en) * 2005-10-11 2007-04-19 Toray Industries, Inc. Therapeutic agent for nausea and/or vomiting
CN101827819B (en) * 2007-08-09 2013-06-12 伦斯勒理工学院 Quaternary opioid carboxamides

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608075B2 (en) 1997-11-03 2003-08-19 The University Of Chicago Use of methylnaltrexone and related compounds
US8552025B2 (en) 2003-04-08 2013-10-08 Progenics Pharmaceuticals, Inc. Stable methylnaltrexone preparation
US9669096B2 (en) 2003-04-08 2017-06-06 Progenics Pharmaceuticals, Inc. Stable pharmaceutical formulations of methylnaltrexone
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
US9717725B2 (en) 2005-03-07 2017-08-01 The University Of Chicago Use of opioid antagonists
US9662390B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US9675602B2 (en) 2005-03-07 2017-06-13 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8343992B2 (en) 2005-05-25 2013-01-01 Progenics Pharmaceuticals, Inc. Synthesis of R-N-methylnaltrexone
US8916581B2 (en) 2005-05-25 2014-12-23 Progenics Pharmaceuticals, Inc. (S)-N-methylnaltrexone
US8003794B2 (en) 2005-05-25 2011-08-23 Progenics Pharmaceuticals, Inc. (S)-N-methylnaltrexone
US7674904B2 (en) 2005-05-25 2010-03-09 Progenics Pharmaceuticals, Inc. Synthesis of R-N-methylnaltrexone
US7563899B2 (en) 2005-05-25 2009-07-21 Progenics Pharmaceuticals, Inc. (S)-N-methylnaltrexone
US9597327B2 (en) 2005-05-25 2017-03-21 Progenics Pharmaceuticals, Inc. Synthesis of (R)-N-methylnaltrexone
US8772310B2 (en) 2007-03-29 2014-07-08 Wyeth Llc Peripheral opioid receptor antagonists and uses thereof
US8546418B2 (en) 2007-03-29 2013-10-01 Progenics Pharmaceuticals, Inc. Peripheral opioid receptor antagonists and uses thereof
US8853232B2 (en) 2007-03-29 2014-10-07 Wyeth Llc Peripheral opioid receptor antagonists and uses thereof
US8338446B2 (en) 2007-03-29 2012-12-25 Wyeth Llc Peripheral opioid receptor antagonists and uses thereof
US9102680B2 (en) 2007-03-29 2015-08-11 Wyeth Llc Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof
US9879024B2 (en) 2007-03-29 2018-01-30 Progenics Pharmaceuticals., Inc. Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof
US8916706B2 (en) 2008-02-06 2014-12-23 Progenics Pharmaceuticals, Inc. Preparation and use of (R),(R)-2,2′-bis-methylnaltrexone
US8471022B2 (en) 2008-02-06 2013-06-25 Progenics Pharmaceuticals, Inc. Preparation and use of (R),(R)-2,2′-bis-methylnaltrexone
US9526723B2 (en) 2008-03-21 2016-12-27 The University Of Chicago Treatment with opioid antagonists and mTOR inhibitors
US8685995B2 (en) 2008-03-21 2014-04-01 The University Of Chicago Treatment with opioid antagonists and mTOR inhibitors
US9180125B2 (en) 2008-09-30 2015-11-10 Wyeth, Llc Peripheral opioid receptor antagonists and uses thereof
US9492445B2 (en) 2008-09-30 2016-11-15 Wyeth, Llc Peripheral opioid receptor antagonists and uses thereof
US8455644B2 (en) 2008-09-30 2013-06-04 Wyeth Peripheral opioid receptor antagonists and uses thereof
US8420663B2 (en) 2008-09-30 2013-04-16 Wyeth Peripheral opioid receptor antagonists and uses thereof
US8247425B2 (en) 2008-09-30 2012-08-21 Wyeth Peripheral opioid receptor antagonists and uses thereof
US9724343B2 (en) 2008-09-30 2017-08-08 Wyeth, Llc Peripheral opioid receptor antagonists and uses thereof
US8822490B2 (en) 2008-09-30 2014-09-02 Wyeth Llc Peripheral opioid receptor antagonists and uses thereof

Also Published As

Publication number Publication date
CA1315689C (en) 1993-04-06
DK693387A (en) 1989-03-04
DK167340B1 (en) 1993-10-18
PH22582A (en) 1988-10-17
JPS6468376A (en) 1989-03-14
DK693387D0 (en) 1987-12-30
JP2625457B2 (en) 1997-07-02

Similar Documents

Publication Publication Date Title
AU620558B2 (en) A process and a composition for immunizing plants against diseases
EG19301A (en) Process for preparing of quinuclidine therapeutic agents
EG19303A (en) Process for preparing of new therapeutically active compound
GB2172313B (en) Apparatus and process for improving a subterranean foundation
US5232438B1 (en) Transdermal electrotransport delivery of analgesic drugs
FI95572B (en) Process for the preparation of a medicament useful piperidine derivatives or a pharmaceutically acceptable salt thereof
EP0357665A4 (en) Rapidly dissoluble medicinal dosage unit and method of manufacture
NO179963B (en) A device for percutaneous administration once daily of nicotine
IN165029B (en) Process of preparing novel complexes of active substances for enhancing absorption thereof on oral administration
NO177882C (en) A method for manufacturing a fuel component for a smoking article, the component of the smoking article and to apparatus for producing such
IE890223L (en) Pre-slit injection site and tapered cannula
HUT36784A (en) Process for producing spasmolytic sulfanate derivatives and pharmaceutical compositions containing them as active agents
DE3573533D1 (en) Method and composition for preventing the adsorption of a medicine
AU5261086A (en) An easy to open package and a method of making same
SU1486064A3 (en) Method of producing derivatives of indolysine or their pharmaceutically acceptable salts
HUT64696A (en) Method for production of preparations containing diphenyl-butyl-piperazine-carboxamides for the treatment of drug addict and drug abuse
EP0494972A4 (en) Effervescent dosage form and method of administering same
ES543828A0 (en) A method of producing a pharmaceutical preparation in unit dosage form of a solid steroid drug
HUT49316A (en) Process for producing didehydro-d3-vitamine derivatives and pharmaceutical compositions containing them
IL86583D0 (en) Vaccine containing a derivative of a microbe and method for the production thereof
DE3412779C1 (en) A method of manufacturing a synchronizing ring
JPS63248965A (en) Device and method of injecting fuel
HUT41790A (en) Process for producing beta-amino-purine derivatives and pharmaceutical compositions containing them
ZA8904728B (en) A new pharmaceutical formulation as well as a process for its preparation
AU6665090A (en) Method and means for treating alcoholism by extinguishing the alcohol-drinking response using a transdermally administered opiate antagonist